# Health Outcomes of Patients With Type 2 Diabetes Treated With Dapagliflozin in Conjunction With Insulin

> **NCT02899949** · — · COMPLETED · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 212 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02899949
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2016-11
- **Final completion:** 2016-12
- **Target enrollment:** 212 (ACTUAL)
- **Last updated:** 2017-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02899949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02899949, "Health Outcomes of Patients With Type 2 Diabetes Treated With Dapagliflozin in Conjunction With Insulin". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02899949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*